HK1064384A1 - Preparation of aminopyrimidine compounds - Google Patents
Preparation of aminopyrimidine compoundsInfo
- Publication number
- HK1064384A1 HK1064384A1 HK04107242A HK04107242A HK1064384A1 HK 1064384 A1 HK1064384 A1 HK 1064384A1 HK 04107242 A HK04107242 A HK 04107242A HK 04107242 A HK04107242 A HK 04107242A HK 1064384 A1 HK1064384 A1 HK 1064384A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- aminopyrimidine compounds
- aminopyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001213417 | 2001-07-13 | ||
| JP2001213418 | 2001-07-13 | ||
| JP2001310900 | 2001-10-09 | ||
| JP2001360339 | 2001-11-27 | ||
| JP2002007015 | 2002-01-16 | ||
| JP2002042076 | 2002-02-19 | ||
| PCT/JP2002/007129 WO2003006439A1 (en) | 2001-07-13 | 2002-07-12 | Preparation of aminopyrimidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1064384A1 true HK1064384A1 (en) | 2005-01-28 |
Family
ID=27554967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04107242A HK1064384A1 (en) | 2001-07-13 | 2004-09-20 | Preparation of aminopyrimidine compounds |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US7304156B2 (de) |
| EP (1) | EP1417180B1 (de) |
| JP (2) | JP4359141B2 (de) |
| KR (1) | KR100888408B1 (de) |
| CN (2) | CN1301977C (de) |
| AR (2) | AR034772A1 (de) |
| AT (1) | ATE349431T1 (de) |
| AU (1) | AU2002318041B2 (de) |
| BR (1) | BR0211072A (de) |
| CA (1) | CA2453505C (de) |
| CO (1) | CO5560574A2 (de) |
| CY (1) | CY1107551T1 (de) |
| DE (1) | DE60217126T2 (de) |
| DK (1) | DK1417180T3 (de) |
| EG (1) | EG24848A (de) |
| ES (1) | ES2278032T3 (de) |
| HK (1) | HK1064384A1 (de) |
| HU (1) | HUP0401248A3 (de) |
| IL (2) | IL159741A0 (de) |
| IS (1) | IS2399B (de) |
| MX (1) | MXPA04000322A (de) |
| MY (1) | MY133579A (de) |
| NO (1) | NO326173B1 (de) |
| NZ (1) | NZ531033A (de) |
| PL (1) | PL366831A1 (de) |
| PT (1) | PT1417180E (de) |
| SI (1) | SI1417180T1 (de) |
| WO (1) | WO2003006439A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011120D0 (en) | 2000-05-09 | 2000-06-28 | Avecia Ltd | Process |
| NL1015744C2 (nl) | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
| ATE349431T1 (de) | 2001-07-13 | 2007-01-15 | Astrazeneca Uk Ltd | Herstellung von aminopyrimidinverbindungen |
| EP1323717A1 (de) | 2001-12-27 | 2003-07-02 | Dsm N.V. | Prozess für die Herstellung von 2-(6-Substituierten-1,3-Dioxan-4-yl) Essigsäure Derivaten |
| EP1375493A1 (de) | 2002-06-17 | 2004-01-02 | Dsm N.V. | Verfahren zur Herstellung von Dioxanessigsäureester |
| GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
| WO2004054986A2 (en) * | 2002-12-16 | 2004-07-01 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
| GB0312896D0 (en) * | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
| UY28501A1 (es) * | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
| GB0324791D0 (en) * | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
| GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
| GB0514078D0 (en) * | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
| US8455640B2 (en) * | 2006-05-03 | 2013-06-04 | Msn Laboratories Limited | Process for statins and its pharmaceutically acceptable salts thereof |
| ES2567171T3 (es) | 2006-10-09 | 2016-04-20 | Msn Laboratories Private Limited | Nuevo procedimiento para la preparación de estatinas y sus sales farmacéuticamente aceptables |
| TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
| CN101323597B (zh) * | 2007-06-11 | 2012-09-05 | 安徽省庆云医药化工有限公司 | 4-(4-氟苯基)-6-异丙基-2-(n-甲基-n-甲磺酰氨基)嘧啶-5-甲醛的制备方法 |
| CN101376647B (zh) * | 2007-08-31 | 2010-12-08 | 中山奕安泰医药科技有限公司 | 一种用于合成瑞舒伐他汀中间体及瑞舒伐他汀的合成方法 |
| WO2009150668A1 (en) * | 2008-06-13 | 2009-12-17 | Delhi University | Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same |
| US8487105B2 (en) | 2009-01-19 | 2013-07-16 | Msn Laboratories Limited | Process for preparing pitavastatin, intermediates and pharmaceuctically acceptable salts thereof |
| US8987444B2 (en) | 2010-01-18 | 2015-03-24 | Msn Laboratories Private Limited | Process for the preparation of amide intermediates and their use thereof |
| EP2423195A1 (de) | 2010-07-26 | 2012-02-29 | LEK Pharmaceuticals d.d. | Verfahren zur Herstellung von wesentlichen Zwischenstufen zur Synthese von Rosuvastatin oder pharmazeutisch annehmbaren Salzen davon |
| CN101955463B (zh) * | 2010-08-04 | 2012-01-04 | 重庆博腾制药科技股份有限公司 | 瑞舒伐他汀钙中间体的制备方法 |
| CN102584717B (zh) * | 2011-01-17 | 2014-12-10 | 浙江九洲药业股份有限公司 | 用于制备罗苏伐他汀的中间体及相关制备方法和用途 |
| CN103483269B (zh) * | 2012-06-13 | 2016-04-27 | 上海迪赛诺药业有限公司 | 瑞舒伐他汀钙及其中间体的制备方法 |
| WO2013185309A1 (zh) * | 2012-06-13 | 2013-12-19 | 上海迪赛诺药业有限公司 | 瑞舒伐他汀钙及其中间体的制备方法 |
| CN103864697A (zh) * | 2012-12-11 | 2014-06-18 | 润泽制药(苏州)有限公司 | 瑞舒伐中间体主链醇的制备方法 |
| CN104059024B (zh) * | 2014-06-16 | 2016-04-06 | 浙江大学 | 瑞舒伐他汀中间体的制备方法及中间体化合物 |
| CN107428703B (zh) * | 2015-01-23 | 2021-01-12 | 灿盛制药有限公司荷兰公司 | 用于制备他汀前体的改进的方法 |
| CN104817505A (zh) * | 2015-04-23 | 2015-08-05 | 南京博优康远生物医药科技有限公司 | 一种制备n-[4-(4-氟苯基)-5-羟甲基-6-异丙基-嘧啶-2-基]-n-甲基甲磺酰胺的方法 |
| CN109912522B (zh) * | 2017-12-12 | 2021-04-13 | 北京颖泰嘉和生物科技股份有限公司 | 制备三唑啉硫酮化合物的方法 |
| CN109081815A (zh) * | 2018-11-12 | 2018-12-25 | 甘肃农业大学 | 一种新型亲电试剂甲磺酸嘧啶酯的制备方法 |
| CN111138369A (zh) * | 2019-12-17 | 2020-05-12 | 上海雅本化学有限公司 | 瑞舒法他汀中间体的制备方法 |
| BR112022019387A2 (pt) * | 2020-03-27 | 2022-11-16 | Dong A St Co Ltd | Derivados de aminopirimidina e seu uso como moduladores de receptores de aril hidrocarbonetos |
| CN112174898B (zh) * | 2020-11-06 | 2021-05-04 | 浙江宏元药业股份有限公司 | 一种连续氧化二氢嘧啶酮制备羟基嘧啶的新方法 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4645858A (en) * | 1982-03-22 | 1987-02-24 | G. D. Searle & Co. | Pentanedioic acid derivatives |
| US4625039A (en) * | 1983-12-21 | 1986-11-25 | Sandoz Pharm. Corp. | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates |
| US4650890A (en) * | 1984-04-03 | 1987-03-17 | Sandoz Corp. | Preparation of olefinic compounds and intermediates thereof |
| US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
| US4677211A (en) * | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
| US4957971A (en) * | 1986-07-07 | 1990-09-18 | Warner-Lambert Company | Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| US5102893A (en) * | 1986-07-07 | 1992-04-07 | Warner-Lambert Company | Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| US4808621A (en) | 1986-07-07 | 1989-02-28 | Warner-Lambert Company | Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| DE3739882A1 (de) * | 1987-11-25 | 1989-06-08 | Bayer Ag | Substituierte hydroxylamine |
| DE3741508A1 (de) | 1987-12-08 | 1989-06-22 | Hoechst Ag | Wasserloesliche disazoverbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbstoffe |
| DE3741509A1 (de) * | 1987-12-08 | 1989-06-22 | Hoechst Ag | Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte |
| GB2244706B (en) | 1988-02-18 | 1992-07-15 | Bristol Myers Co | Preparation of antihypercholesterolemic tetrazole intermediates |
| EP0367895A1 (de) | 1988-10-06 | 1990-05-16 | Sandoz Ag | Pyrimidinyl substituierte Hydroxysäuren, Laktone und Ester und diese enthaltende pharmazeutische Zusammenstellungen |
| FR2665159B1 (fr) | 1990-07-24 | 1992-11-13 | Rhone Poulenc Sante | Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| IE914005A1 (en) * | 1990-12-14 | 1992-06-17 | Zeneca Ltd | Novel intermediates |
| JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| WO1993008823A1 (en) | 1991-11-06 | 1993-05-13 | Tanabe Seiyaku Co., Ltd. | Guanidinyl and related cell adhesion modulation compounds |
| US5278313A (en) * | 1992-03-27 | 1994-01-11 | E. R. Squibb & Sons, Inc. | Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors |
| ATE158579T1 (de) * | 1992-07-02 | 1997-10-15 | Hoechst Ag | Verfahren zur herstellung von (3r,5s)6-hydroxy- 3,5-0-isopropyliden-3,5-dihydroxy-hexansäure- tert.-butylester |
| JP3197971B2 (ja) | 1993-03-01 | 2001-08-13 | 塩野義製薬株式会社 | ５−カルボアルコキシピリミジン誘導体の合成方法 |
| SK60097A3 (en) | 1994-11-16 | 1998-01-14 | Synaptic Pharma Corp | Dihydropyrimidines, pharmaceutical composition containing same and use thereof |
| DE19517186A1 (de) | 1995-05-11 | 1996-11-14 | Bayer Ag | Verfahren zur Herstellung substituierter 2-Fluor-pyrimidine |
| FR2741620B1 (fr) | 1995-11-28 | 1997-12-26 | Oreal | Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline |
| US6278001B1 (en) * | 1995-11-28 | 2001-08-21 | L'oréal | Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping |
| CZ184098A3 (cs) | 1995-12-14 | 1998-11-11 | Merck And Co., Inc. | Způsob výroby dihydropyrimidinonů |
| JP2001512724A (ja) | 1997-08-05 | 2001-08-28 | メルク エンド カムパニー インコーポレーテッド | α１ａアドレナリン受容体拮抗薬 |
| JP4440476B2 (ja) * | 1998-12-10 | 2010-03-24 | 株式会社カネカ | シンバスタチンの製造方法 |
| GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
| EP1193259A4 (de) | 1999-06-23 | 2003-01-29 | Ajinomoto Kk | Dihydropyrimidinderivate |
| WO2001004336A1 (de) | 1999-07-09 | 2001-01-18 | Forschungszentrum Jülich GmbH | Verfahren zur reduktion von keto-carbonsäuren und deren estern |
| WO2001004100A1 (en) * | 1999-07-13 | 2001-01-18 | Lonza Ag | Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate |
| GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| AU2000254249A1 (en) | 2000-03-28 | 2001-10-08 | Biocon India Limited | Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1- |
| GB0011120D0 (en) * | 2000-05-09 | 2000-06-28 | Avecia Ltd | Process |
| GB0011163D0 (en) | 2000-05-10 | 2000-06-28 | Astrazeneca Ab | Chemical compound |
| US8374574B1 (en) | 2000-07-06 | 2013-02-12 | Motorola Mobility Llc | Method and apparatus for storing a message for playback during a user-initiated emergency telephone call from a wireless device |
| NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
| PL367133A1 (en) * | 2001-06-06 | 2005-02-21 | Bristol-Myers Squibb Company | Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| CN101880227A (zh) | 2001-07-06 | 2010-11-10 | 西巴特殊化学品控股有限公司 | 一种用于制备适合于制备他汀类衍生物的中间体化合物的方法及其中间体 |
| ATE349431T1 (de) | 2001-07-13 | 2007-01-15 | Astrazeneca Uk Ltd | Herstellung von aminopyrimidinverbindungen |
| CN1545502A (zh) | 2001-08-22 | 2004-11-10 | �������⻯ѧƷ�ع�����˾ | 吲哚衍生物的制备方法 |
| EP1323717A1 (de) * | 2001-12-27 | 2003-07-02 | Dsm N.V. | Prozess für die Herstellung von 2-(6-Substituierten-1,3-Dioxan-4-yl) Essigsäure Derivaten |
| US6835838B2 (en) | 2002-01-28 | 2004-12-28 | Novartis Ag | Process for the manufacture of organic compounds |
| KR100511533B1 (ko) | 2002-04-09 | 2005-08-31 | 임광민 | 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법 |
| US20050222415A1 (en) | 2002-05-21 | 2005-10-06 | Yatendra Kumar | Process for the preparation of rosuvastatin |
| EP1375493A1 (de) * | 2002-06-17 | 2004-01-02 | Dsm N.V. | Verfahren zur Herstellung von Dioxanessigsäureester |
| GB0218781D0 (en) * | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
| SI1578733T1 (sl) | 2002-12-10 | 2011-07-29 | Ranbaxy Lab Ltd | Postopek za pridobitev rosuvastatina |
| WO2004054986A2 (en) | 2002-12-16 | 2004-07-01 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
| WO2004103977A2 (en) | 2003-05-21 | 2004-12-02 | Ciba Specialty Chemicals Holding Inc. | Process for the preparation of pyrimidine derivatives |
| GB0312896D0 (en) * | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
| UY28501A1 (es) * | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
| GB0321827D0 (en) * | 2003-09-18 | 2003-10-15 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
| DE10352659B4 (de) * | 2003-11-11 | 2007-09-13 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren |
| WO2005054207A1 (en) * | 2003-12-04 | 2005-06-16 | Glenmark Pharmaceuticals Limited | Process for the preparation of pyrimidine derivatives |
| EP1697338A2 (de) | 2003-12-24 | 2006-09-06 | Teva Pharmaceutical Industries Ltd. | Verfahren zur herstellung von statinen mit hohem syn-zu-anti-verhältnis |
| GB0406757D0 (en) | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
| GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
| CA2498978A1 (en) | 2005-02-28 | 2006-08-28 | Apotex Pharmachem Inc. | An improved process for the preparation of atorvastatin and intermediates |
| GB0514078D0 (en) | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
| TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
| EP2314945B1 (de) | 2008-10-29 | 2017-07-26 | Mitsubishi Electric Corporation | Klimaanlage |
-
2002
- 2002-07-12 AT AT02747666T patent/ATE349431T1/de active
- 2002-07-12 WO PCT/JP2002/007129 patent/WO2003006439A1/en active IP Right Grant
- 2002-07-12 CN CNB028141237A patent/CN1301977C/zh not_active Expired - Lifetime
- 2002-07-12 NZ NZ531033A patent/NZ531033A/en not_active IP Right Cessation
- 2002-07-12 KR KR1020047000545A patent/KR100888408B1/ko not_active IP Right Cessation
- 2002-07-12 PT PT02747666T patent/PT1417180E/pt unknown
- 2002-07-12 CN CNB2005101064232A patent/CN100349877C/zh not_active Expired - Lifetime
- 2002-07-12 MY MYPI20022650A patent/MY133579A/en unknown
- 2002-07-12 US US10/483,430 patent/US7304156B2/en not_active Expired - Lifetime
- 2002-07-12 AR ARP020102617A patent/AR034772A1/es not_active Application Discontinuation
- 2002-07-12 EP EP02747666A patent/EP1417180B1/de not_active Expired - Lifetime
- 2002-07-12 MX MXPA04000322A patent/MXPA04000322A/es active IP Right Grant
- 2002-07-12 HU HU0401248A patent/HUP0401248A3/hu unknown
- 2002-07-12 JP JP2003512211A patent/JP4359141B2/ja not_active Expired - Lifetime
- 2002-07-12 DE DE60217126T patent/DE60217126T2/de not_active Expired - Lifetime
- 2002-07-12 PL PL02366831A patent/PL366831A1/xx not_active IP Right Cessation
- 2002-07-12 ES ES02747666T patent/ES2278032T3/es not_active Expired - Lifetime
- 2002-07-12 IL IL15974102A patent/IL159741A0/xx unknown
- 2002-07-12 BR BR0211072-5A patent/BR0211072A/pt not_active IP Right Cessation
- 2002-07-12 SI SI200230492T patent/SI1417180T1/sl unknown
- 2002-07-12 AU AU2002318041A patent/AU2002318041B2/en not_active Ceased
- 2002-07-12 DK DK02747666T patent/DK1417180T3/da active
- 2002-07-12 CA CA2453505A patent/CA2453505C/en not_active Expired - Fee Related
-
2004
- 2004-01-06 IL IL159741A patent/IL159741A/en not_active IP Right Cessation
- 2004-01-09 CO CO04001313A patent/CO5560574A2/es not_active Application Discontinuation
- 2004-01-10 EG EGNA2004000002 patent/EG24848A/xx active
- 2004-01-12 IS IS7103A patent/IS2399B/is unknown
- 2004-01-12 NO NO20040122A patent/NO326173B1/no unknown
- 2004-09-20 HK HK04107242A patent/HK1064384A1/xx not_active IP Right Cessation
-
2007
- 2007-03-06 CY CY20071100309T patent/CY1107551T1/el unknown
- 2007-11-01 US US11/933,626 patent/US7816528B2/en not_active Expired - Lifetime
-
2008
- 2008-11-19 JP JP2008295840A patent/JP5016583B2/ja not_active Expired - Lifetime
-
2010
- 2010-09-23 US US12/889,186 patent/US8222412B2/en not_active Expired - Lifetime
-
2011
- 2011-09-01 AR ARP110103194A patent/AR082864A2/es not_active Application Discontinuation
-
2012
- 2012-06-14 US US13/523,534 patent/US8614320B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24848A (en) | Preparation of aminopyrimidine compounds | |
| HK1208446A1 (en) | Derivatives of uk-2a uk-2a | |
| HK1070071A1 (en) | New pyrimidine compounds | |
| IL162189A0 (en) | Pyrimidine compounds | |
| IL166591A0 (en) | Preparation of aztreonam | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| IL161178A0 (en) | MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES | |
| GB0115385D0 (en) | Novel preparation | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| IL157243A0 (en) | Preparation of n-methylparoxetine and related intermediate compounds | |
| TW493722U (en) | Improved structure of lampwick | |
| GB0118009D0 (en) | Novel preparation | |
| HU0104370D0 (en) | Honeyed schnaps of oerseg | |
| AU2002359898A1 (en) | Preparation of alpha-diimines | |
| IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
| AU2002338934A1 (en) | Preparation of benzosuberonylpiperidine compounds | |
| TW573751U (en) | Structure capable of preventing jaming | |
| GB0124244D0 (en) | Forming of components | |
| GB0125482D0 (en) | Uses of (s)-clenbuterol | |
| GB0109520D0 (en) | Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors | |
| AU2002300773A1 (en) | Preparation of Dialkylpyridylboranes | |
| TW531140U (en) | Structure of magnet-powered pan | |
| TW501859U (en) | Improvement of fixing-stand structure | |
| TW494780U (en) | Structure of swimmeret | |
| TW573511U (en) | Structure of cup |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20220711 |